The role of specific genes in transplant arteriosclerosis: Studies in mutant mice

Transplant Immunology

Volumn 5, Issue 4, 1997, Pages 293-297

  Haber, Edgar ^a,b   Shi, Chengwei ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b 677 Huntington Avenue ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ARTERIOSCLEROSIS; GENE; GENE MUTATION; HYPERCHOLESTEROLEMIA; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TRANSPLANTATION;

EID: 0031438241     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80011-1     Document Type: Article

References (28)

1. Shi C, Russell ME, Bianchi C, et al. Murine model of accelerated transplant arteriosclerosis. Circ Res. 75:1994;199-207.
2. Corry RJ, Winn HJ, Russell PS. Heart transplantation in congenic strains of mice. Transplant Proc. 5:1973;733-735.
3. Shinkai Y, Rathbun G, Lam K-P, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V. (D)J rearrangement Cell. 68:1992;855-867.
4. Shi C, Lee W-S, He Q, et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci USA. 93:1996;4051-4056.
5. Grusby MJ, Johnson RS, Papaioannou VE, et al. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science. 253:1991;1417-1420.
6. McCarrick JW III, Parnes JR, Seong RH, et al. Positive-negative selection gene targeting with the diphtheria toxin A-chain gene in mouse embryonic stem cells. Transgenic Res. 2:1993;183-190.
7. Koller BH, Marrack P, Kapper JW, et al. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science. 248:1990;1227-1230.
8. Kitamura D, Roes J, Kühn R, et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 350:1991;423-426.
9. Wiktor-Jedrzejczak W, Ahmed A, Szczylik C, et al. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med. 156:1982;1516-1527.
10. Roder J, Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 278:1979;451-453.
11. Hruban RH, Beschorner WE, Baumgartner WA, et al. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol. 137:1990;871-882.
12. Sarris GE, Moore KA, Schroeder JS, et al. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg. 108:1994;240-251.
13. Eich D, Thompson JA, Ko DJ, et al. Hypercholesterolemia in longterm survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant. 10:1991;45-49.
14. Sharples LD, Caine N, Mullins P, et al. Risk factor analysis for the major hazards following heart transplantation - rejection infection and coronary occlusive disease. Transplantation. 52:1991;244-252.
15. Gao SZ, Schroeder JS, Hunt S, et al. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol. 62:1988;876-881.
16. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 333:1995;621-627.
17. Tanaka H, Sukhova GK, Libby P. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb. 14:1994;734-745.
18. Alonso DR, Starek PK, Minick CR. Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol. 87:1977;415-442.
19. Adams DH, Karnovsky MJ. Hypercholesterolemia does not exacerbate arterial intimal thickening in chronically rejecting rat cardiac allografts. Transplant Proc. 21:1989;437-439.
20. Russell PS, Chase CM, Colvin RB. Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients. Am J Pathol. 149:1996;91-99.
21. Piedrahita JA, Zhang SH, Hagaman JR, et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA. 89:1992;4471-4475.
22. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
23. Johnson DE, Gao SZ, Schroeder JS, et al. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant. 8:1989;349-359.
24. Wang N, Tabas I, Winchester R, et al. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem. 271:1996;8837-8842.
25. Yue TL, Wang X, Sung CP, et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ Res. 75:1994;1-7.
26. Bozic CR, Gerard NP, von Uexkull-Guldenband C, et al. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem. 269:1994;29355-29358.
27. Heinrich JN, Bravo R. The orphan mouse receptor interleukin (IL)-8Rb binds N51. Structure - function analysis using N51/IL-8 chimeric molecules. J Biol Chem. 270:1995;4987-4989.
28. 125I-interleukin (IL)-8 binding to IL-8Rb but not IL-8Ra. Structure - function analysis using N51/IL-8 chimeric molecules. J Biol Chem. 270:1995;28014-28017.